Category In The News

November 4, 2013 10:56 AM
Thanks To Our Race Towards A Cure Marine Corps Marathon and MCM10k Team!

With the support of many friends, co-workers and family, our team has raised over $59,000 for brain tumor research.

October 29, 2013 04:31 PM
ABC2 Collaboration Fuels New Pediatric Vaccine Trial at University of Florida

The Phase II trial is led by Dr. Duane Mitchell, director of the UF Brain Tumor Immunotherapy Program.

October 21, 2013 01:45 PM
Max Wallace Talks Innovation at Congress of Neurological Surgeons Annual Meeting

Key industry and foundation leaders were invited to share their disruptive ideas on the future of neurosurgery at the new CNS Neurosurgery Innovations Symposium.

October 15, 2013 04:37 PM
NCI/ABC2 Co-host Groundbreaking Clinical Trials Conference

A letter to the brain tumor community from Max Wallace, CEO of Accelerate Brain Cancer Cure.

October 11, 2013 02:40 PM
The Cancer Genome Atlas exposes more secrets of lethal brain tumor

The Oct. 10 issue of Cell looks at the progress made by The Cancer Genome Atlas since its launch five years ago.

October 8, 2013 10:38 AM
Three Americans win Nobel Prize in medicine for work on traffic control system of cells

While the honorees expressed gratitude for the prize, their comments about their work were tinged with worry about the future of biomedical research after years of cuts in federal funding.

September 26, 2013 04:33 PM
Johns Hopkins Researchers Erase Human Brain Tumor Cells In Mice

The researchers caution that many treatments have cured cancers in mice and then failed in humans. But they are encouraged by the new findings and want to work quickly to design a clinical trial for humans.

September 17, 2013 01:30 PM
Brain Cancer Vaccine Gets Positive Phase 2 Results

Accelerate Brain Cancer Cure helped fund the Phase 2 trial led by Dr. Andrew Parsa, Chair of Neurosurgery at Northwestern Memorial Hospital.

August 23, 2013 12:51 PM
New Mayo Clinic Study: Avastin Boosts Survival in GBM

Researchers found that there was a “highly significant” increase in GBM patient survival in the year after Avastin was approved.

June 21, 2013 04:06 PM
Agios Files IPO To Advance Cancer Metabolism Research

Accelerate Brain Cancer Cure was an early investor in Agios to support its novel research into IDH1 gene mutation in brain cancer.   


Share |

Join us in our fight for a cure!